SANGAMO THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Deferred Tax Assets, Operating Loss Carryforwards of $255.86 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $255.86M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $211.59M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $196.72M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $174.13M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $255.86M 10-K · filed 2026-03-30 |
| 2024-12-31 | $211.59M 10-K · filed 2026-03-30 |
| 2023-12-31 | $196.72M 10-K · filed 2025-03-17 |
| 2022-12-31 | $174.13M 10-K · filed 2024-03-13 |
| 2021-12-31 | $159.74M 10-K · filed 2023-02-23 |
| 2020-12-31 | $164.28M 10-K · filed 2022-02-24 |
| 2019-12-31 | $133.76M 10-K · filed 2021-02-24 |
| 2018-12-31 | $138.90M 10-K · filed 2020-02-28 |
| 2017-12-31 | $91.31M 10-K · filed 2019-03-01 |
| 2016-12-31 | $114.22M 10-K · filed 2018-03-01 |
| 2015-12-31 | $93.82M 10-K · filed 2017-02-28 |
| 2014-12-31 | $90.92M 10-K · filed 2016-02-18 |
| 2013-12-31 | $81.94M 10-K · filed 2015-02-25 |
| 2012-12-31 | $73.13M 10-K · filed 2014-02-24 |
| 2011-12-31 | $67.39M 10-K · filed 2013-02-26 |